CA2400526C - Method and apparatus for destroying dividing cells - Google Patents
Method and apparatus for destroying dividing cells Download PDFInfo
- Publication number
- CA2400526C CA2400526C CA2400526A CA2400526A CA2400526C CA 2400526 C CA2400526 C CA 2400526C CA 2400526 A CA2400526 A CA 2400526A CA 2400526 A CA2400526 A CA 2400526A CA 2400526 C CA2400526 C CA 2400526C
- Authority
- CA
- Canada
- Prior art keywords
- electric field
- cells
- dividing cells
- cell
- dividing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract description 56
- 230000005684 electric field Effects 0.000 claims abstract description 117
- 230000006378 damage Effects 0.000 claims abstract description 33
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 24
- 230000007017 scission Effects 0.000 claims abstract description 24
- 230000003834 intracellular effect Effects 0.000 claims abstract description 21
- 230000031016 anaphase Effects 0.000 claims abstract description 11
- 230000001965 increasing effect Effects 0.000 claims abstract description 10
- 230000016853 telophase Effects 0.000 claims abstract description 10
- 230000033001 locomotion Effects 0.000 abstract description 12
- 230000004044 response Effects 0.000 abstract description 7
- 210000004027 cell Anatomy 0.000 description 202
- 210000001519 tissue Anatomy 0.000 description 53
- 206010028980 Neoplasm Diseases 0.000 description 30
- 239000012528 membrane Substances 0.000 description 29
- 230000008569 process Effects 0.000 description 23
- 210000004881 tumor cell Anatomy 0.000 description 22
- 238000011282 treatment Methods 0.000 description 17
- 210000005061 intracellular organelle Anatomy 0.000 description 13
- 230000032823 cell division Effects 0.000 description 11
- 210000000170 cell membrane Anatomy 0.000 description 11
- 210000003463 organelle Anatomy 0.000 description 10
- 210000000349 chromosome Anatomy 0.000 description 8
- 230000001419 dependent effect Effects 0.000 description 8
- 210000000805 cytoplasm Anatomy 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 239000004020 conductor Substances 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 230000003211 malignant effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 108091060290 Chromatid Proteins 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004718 centriole Anatomy 0.000 description 3
- 210000004756 chromatid Anatomy 0.000 description 3
- 230000021953 cytokinesis Effects 0.000 description 3
- 238000010291 electrical method Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000002977 intracellular fluid Anatomy 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000031877 prophase Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 210000000777 hematopoietic system Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 235000012771 pancakes Nutrition 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000009798 Craniopharyngioma Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000007054 Medullary Carcinoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000007452 Plasmacytoma Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000014070 Vestibular schwannoma Diseases 0.000 description 1
- 208000008383 Wilms tumor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 201000007180 bile duct carcinoma Diseases 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000002445 cystadenocarcinoma Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000037828 epithelial carcinoma Diseases 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003313 haploid nucleated cell Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000002222 hemangioblastoma Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000011379 keloid formation Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
- 208000012804 lymphangiosarcoma Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 206010027191 meningioma Diseases 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 208000037819 metastatic cancer Diseases 0.000 description 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 208000001611 myxosarcoma Diseases 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 201000010198 papillary carcinoma Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 201000010965 sweat gland carcinoma Diseases 0.000 description 1
- 206010042863 synovial sarcoma Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/147—Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18329500P | 2000-02-17 | 2000-02-17 | |
| US60/183,295 | 2000-02-17 | ||
| PCT/IB2001/000202 WO2001060994A1 (en) | 2000-02-17 | 2001-02-16 | Method and apparatus for destroying dividing cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2400526A1 CA2400526A1 (en) | 2001-08-23 |
| CA2400526C true CA2400526C (en) | 2013-04-23 |
Family
ID=22672230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2400526A Expired - Lifetime CA2400526C (en) | 2000-02-17 | 2001-02-16 | Method and apparatus for destroying dividing cells |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7333852B2 (enExample) |
| EP (2) | EP2335776A1 (enExample) |
| JP (1) | JP5280600B2 (enExample) |
| CN (1) | CN1416466A (enExample) |
| AU (1) | AU3399801A (enExample) |
| CA (1) | CA2400526C (enExample) |
| WO (1) | WO2001060994A1 (enExample) |
Families Citing this family (146)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7016725B2 (en) | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
| US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
| US6868289B2 (en) * | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
| US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
| US7136699B2 (en) | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
| JP5280600B2 (ja) | 2000-02-17 | 2013-09-04 | パルティ、ヨーラム | 分裂中の細胞を破壊するための方法および装置 |
| US7146210B2 (en) | 2000-02-17 | 2006-12-05 | Standen Ltd. | Apparatus and method for optimizing tumor treatment efficiency by electric fields |
| US8447395B2 (en) | 2000-02-17 | 2013-05-21 | Novocure Ltd | Treating bacteria with electric fields |
| US7089054B2 (en) | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
| JP4750784B2 (ja) | 2004-04-23 | 2011-08-17 | ノヴォキュアー・リミテッド | 異なる周波数の電界による腫瘍等の治療 |
| WO2006061688A1 (en) | 2004-12-07 | 2006-06-15 | Standen Ltd. | Electrodes for applying an electric field in-vivo over an extended period of time |
| JP5559460B2 (ja) * | 2004-12-27 | 2014-07-23 | スタンデン・リミテッド | 異なる配向の電界を用いて腫瘍またはその類似物を処理する方法 |
| US20070021803A1 (en) | 2005-07-22 | 2007-01-25 | The Foundry Inc. | Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction |
| DK1933937T3 (en) * | 2005-10-03 | 2015-04-07 | Novocure Ltd | OPTIMIZATION OF THE CHARACTERISTICS OF AN ELECTRIC FIELD FOR ENHANCING FIELD EFFECT ON proliferating cells |
| US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
| US8109926B2 (en) | 2006-09-14 | 2012-02-07 | Lazure Scientific, Inc. | Ablation probe with deployable electrodes |
| WO2008098298A1 (en) * | 2007-02-16 | 2008-08-21 | Iogenyx Pty Ltd | Methods for improving the cultivation of aquatic organisms |
| US8465533B2 (en) | 2007-03-06 | 2013-06-18 | Novocure Limited | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
| EP2183024B1 (en) | 2007-08-14 | 2019-05-15 | Novocure Ltd. | Treating parasites with electric fields |
| US20090076500A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
| WO2009036457A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-layer electrode ablation probe and related methods |
| WO2009036468A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Transurethral systems and methods for ablation treatment of prostate tissue |
| US20100100093A1 (en) * | 2008-09-16 | 2010-04-22 | Lazure Technologies, Llc. | System and method for controlled tissue heating for destruction of cancerous cells |
| US8728139B2 (en) | 2009-04-16 | 2014-05-20 | Lazure Technologies, Llc | System and method for energy delivery to a tissue using an electrode array |
| US9526911B1 (en) | 2010-04-27 | 2016-12-27 | Lazure Scientific, Inc. | Immune mediated cancer cell destruction, systems and methods |
| US9233257B1 (en) | 2010-11-22 | 2016-01-12 | Jacob Zabara | Electromagnetic radiation treatment |
| US8684901B1 (en) | 2010-11-22 | 2014-04-01 | Jacob Zabara | Electromagnetic radiation treatment for cancer and pathological genetic regulations |
| CA2826770C (en) | 2011-02-15 | 2020-06-23 | Hemosonics, Llc | Characterization of blood hemostasis and oxygen transport parameters |
| US9757582B2 (en) * | 2012-10-26 | 2017-09-12 | Robert E. Sandstrom | Tumor treatment with free radical lifetimes enhanced by persistant low strength magnetic field |
| US9789328B2 (en) * | 2012-10-26 | 2017-10-17 | Robert E. Sandstrom | Tumor treatment with free radical lifetimes enhanced by persistent low strength magnetic field |
| US9655669B2 (en) | 2013-05-06 | 2017-05-23 | Novocure Limited | Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment |
| US10779875B2 (en) | 2013-05-06 | 2020-09-22 | Novocure Gmbh | Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment |
| US20190117963A1 (en) | 2014-07-25 | 2019-04-25 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
| US9833617B2 (en) | 2014-07-25 | 2017-12-05 | Loyalty Based Innovations, LLC | Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields |
| US9726647B2 (en) | 2015-03-17 | 2017-08-08 | Hemosonics, Llc | Determining mechanical properties via ultrasound-induced resonance |
| US10188851B2 (en) | 2015-10-28 | 2019-01-29 | Novocure Limited | TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements |
| US10821283B2 (en) | 2016-04-04 | 2020-11-03 | Novocure Gmbh | Reducing motility of cancer cells using tumor treating fields (TTFields) |
| AU2017289870B2 (en) | 2016-06-30 | 2021-12-23 | Novocure Gmbh | Arrays for longitudinal delivery of TTFields to a body |
| WO2018134733A1 (en) | 2017-01-19 | 2018-07-26 | Moshe Giladi | System for viewing cell cultures under a microscope whilst applying ttfields |
| US12403306B2 (en) | 2017-10-23 | 2025-09-02 | Cardiac Pacemakers, Inc. | Electric field shaping leads for treatment of cancer |
| US11338135B2 (en) | 2017-10-23 | 2022-05-24 | Cardiac Pacemakers, Inc. | Medical devices for cancer therapy with electric field shaping elements |
| CO2018001283A1 (es) | 2018-02-07 | 2019-08-09 | Panacea Quantum Leap Tech Llc | Método de estimulación de tejidos con campos eléctricos y magnéticos por barrido en frecuencia |
| US10953209B2 (en) | 2018-03-28 | 2021-03-23 | Board Of Regents Of The University Of Texas System | Treating tumors using TTFields combined with a PARP inhibitor |
| US11298422B2 (en) | 2018-04-09 | 2022-04-12 | Novocure Gmbh | Treating tumors with TTFields and an aurora kinase inhibitor |
| PL3775956T3 (pl) | 2018-04-10 | 2022-10-10 | Novocure Gmbh | Szacunki przewodności ac o niskiej częstotliwości (< 1 mhz) pozyskane z dwóch obrazów mri o różnych czasach repetycji |
| CN116603165A (zh) | 2018-07-03 | 2023-08-18 | 斯坦福大学托管董事会 | 使用交变电场提高细胞膜通透性 |
| US11179322B2 (en) | 2018-07-10 | 2021-11-23 | Novocure Gmbh | Methods and compositions for treating tumors with TTFields and sorafenib |
| CA3103070C (en) | 2018-07-10 | 2024-01-09 | Novocure Gmbh | Inhibiting viral infection using alternating electric fields |
| MX2020013431A (es) | 2018-07-18 | 2021-05-27 | Novocure Gmbh | Uso de densidad de perdida de potencia y mediciones relacionadas para cuantificar la dosis de campos de tratamiento de tumores (ttfield). |
| KR20250069692A (ko) | 2018-08-23 | 2025-05-19 | 카스텐 하게만 | 뇌-혈액 장벽 투과성을 향상시키기 위한 교번 전기장의 이용 |
| US11160977B2 (en) | 2018-09-04 | 2021-11-02 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the infratentorial brain |
| CN112770806B (zh) | 2018-09-07 | 2025-12-05 | 诺沃库勒有限责任公司 | 使用交变电场治疗自身免疫性疾病以减少t细胞的增殖 |
| US11986647B2 (en) | 2018-09-07 | 2024-05-21 | Novocure Gmbh | Treating autoinflammatory and mitochondrial diseases using an alternating electric field |
| CN118925056A (zh) | 2018-10-15 | 2024-11-12 | 诺沃库勒有限责任公司 | 生成遍及大脑具有高均匀性的肿瘤治疗场（ttfields） |
| US11369790B2 (en) | 2018-10-25 | 2022-06-28 | Novocure Gmbh | Delivering alternating electric fields (e.g., TTFields) to a subject's spinal anatomy |
| EP3880299B1 (en) | 2018-11-13 | 2025-09-24 | The Methodist Hospital | Device for oncomagnetic treatment |
| KR102747887B1 (ko) | 2018-11-19 | 2024-12-27 | 노보큐어 게엠베하 | 선택적으로 주소 지정 가능한 하위 요소를 하지는 종양 치료장 제공을 위한 어레이 |
| SG11202101810SA (en) | 2018-11-29 | 2021-03-30 | Novocure Gmbh | Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields) |
| CN113330485B (zh) | 2019-01-08 | 2025-09-26 | 诺沃库勒有限责任公司 | 评估将图像分割成不同类型组织的质量，用于使用肿瘤治疗场（TTField）来计划治疗 |
| US11554262B2 (en) | 2019-02-26 | 2023-01-17 | Novocure Gmbh | Determining a frequency for TTFields treatment based on an electrical characteristic of targeted cancer cells |
| EP3954314B1 (en) | 2019-02-27 | 2025-01-08 | Novocure GmbH | Delivering tumor treating fields (ttfields) using implantable transducer arrays |
| EP3988099B1 (en) | 2019-03-29 | 2023-06-07 | Novocure GmbH | Methods for restoring sensitivity to ttfields in ttfields-resistant cancer cells with ptger3 inhibitors |
| EP3924039B1 (en) | 2019-04-17 | 2023-11-22 | Novocure GmbH | Uploading data from an isolated system without compromising isolation |
| JP7410176B2 (ja) | 2019-04-22 | 2024-01-09 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 癌を治療するために電気刺激を与えるためのシステム |
| CN113766948B (zh) | 2019-04-22 | 2025-02-07 | 波士顿科学国际有限公司 | 对癌症的电与化学组合治疗 |
| JP7593942B2 (ja) | 2019-04-22 | 2024-12-03 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 癌治療のための電気刺激機器 |
| WO2020219517A2 (en) | 2019-04-23 | 2020-10-29 | Boston Scientific Scimed, Inc. | Electrical stimulation for cancer treatment with internal and external electrodes |
| JP7476231B2 (ja) | 2019-04-23 | 2024-04-30 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 温熱療法又は熱モニタと共に行われる電気刺激 |
| EP3958956B1 (en) | 2019-04-23 | 2024-02-28 | Boston Scientific Scimed Inc. | Electrodes for electrical stimulation to treat cancer |
| CN114364432B (zh) | 2019-07-31 | 2025-10-31 | 诺沃库勒有限责任公司 | 经由埋入颅骨植入物中的电极施加肿瘤治疗场（TTField） |
| US12343336B2 (en) | 2019-08-05 | 2025-07-01 | Novocure Gmbh | Increasing cancer cells' sensitivity to tumor treating fields (TTFields) by inhibiting IL11 activity |
| US11890467B2 (en) | 2019-08-30 | 2024-02-06 | Novocure Gmbh | Delivering tumor treating fields (TTFields) to the neck |
| EP4038035A1 (de) | 2019-09-30 | 2022-08-10 | TDK Electronics AG | Polykristalliner keramischer festkörper, dielektrische elektrode mit dem festkörper, vorrichtung mit der elektrode und verfahren zur herstellung |
| US11534601B2 (en) | 2019-11-08 | 2022-12-27 | Novocure Gmbh | Perforated hydrogel configurations and methods of production and use thereof |
| WO2021111186A1 (en) | 2019-12-02 | 2021-06-10 | Novocure Gmbh | Methods and apparatuses for optimizing transducer array placement |
| CA3163315A1 (en) | 2019-12-31 | 2021-07-08 | Novocure Gmbh | High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels |
| TWI902740B (zh) | 2019-12-31 | 2025-11-01 | 瑞士商諾沃庫勒有限責任公司 | 用於影像分割之方法、系統和設備 |
| CN114830248A (zh) | 2019-12-31 | 2022-07-29 | 诺沃库勒有限责任公司 | 用于电场分布的快速近似的方法、系统和装置 |
| US12121739B2 (en) | 2019-12-31 | 2024-10-22 | Novocure Gmbh | Methods, systems, and apparatuses for managing temperatures induced by alternating fields |
| DK4074367T3 (da) | 2019-12-31 | 2023-05-22 | Novocure Gmbh | Arrays til levering af tumorbehandlingsfelter (tt-felter) med individuelt tilgængelige elektrodeelementer og temperatursensorer |
| WO2021150877A1 (en) | 2020-01-22 | 2021-07-29 | Novocure Gmbh | Assemblies containing two conductive gel compositions and methods of production and use thereof |
| EP4110455B1 (en) | 2020-02-24 | 2024-05-22 | Boston Scientific Scimed, Inc. | Systems for treatment of pancreatic cancer |
| US20210299440A1 (en) | 2020-03-30 | 2021-09-30 | Novocure Gmbh | Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases |
| WO2021214693A1 (en) | 2020-04-24 | 2021-10-28 | Novocure Gmbh | Using alternating electric fields to increase permeability of the blood brain barrier |
| WO2021223684A1 (zh) * | 2020-05-02 | 2021-11-11 | 电冷科学有限公司 | 一种避免活性非消融电极附近组织损伤的装置 |
| TW202537657A (zh) | 2020-05-06 | 2025-10-01 | 瑞士商諾沃庫勒有限責任公司 | 用於產生腫瘤治療電場之導電襯墊以及生產和使用其之方法 |
| EP4168108A4 (en) | 2020-06-19 | 2024-07-17 | The Methodist Hospital dba Houston Methodist Hospital | METHOD AND APPARATUS FOR ONCOMAGNETIC TREATMENT |
| US11818943B2 (en) | 2020-06-25 | 2023-11-14 | Novocure Gmbh | Fabricating organic light emitting diodes (OLEDs) using tubulin |
| EP4188380A1 (en) * | 2020-08-03 | 2023-06-07 | Novocure GmbH | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields |
| CN114075508A (zh) * | 2020-08-14 | 2022-02-22 | 上海必修福企业管理有限公司 | 电场发生装置及其在影响细胞的分裂周期中的用途和方法 |
| EP4223364B1 (en) | 2020-09-25 | 2024-04-24 | Novocure GmbH | Varying the metallization area on individual electrode elements in a tumor treating fields system to maximize current without overheating |
| DE102020133165B9 (de) | 2020-12-11 | 2024-06-06 | Tdk Electronics Ag | Keramikelektrode, Baugruppe mit der Keramikelektrode, Anordnung mit der Keramikelektrode und Verfahren zur Herstellung einer Keramikelektrode |
| CN116782980A (zh) | 2020-12-21 | 2023-09-19 | 诺沃库勒有限责任公司 | 复合电极的优化 |
| WO2022175803A1 (en) | 2021-02-17 | 2022-08-25 | Novocure Gmbh | Arrays for delivering tumor treating fields (ttfields) with sets of electrode elements having individually adjustable active areas |
| WO2022190068A1 (en) | 2021-03-12 | 2022-09-15 | Novocure Gmbh | Methods of treating disease by skewing macrophage phenotype with alternating electric fields |
| JP2024514045A (ja) | 2021-03-12 | 2024-03-28 | ノボキュア ゲーエムベーハー | 電極アレイ、ならびにその製造および使用方法 |
| WO2022195542A2 (en) | 2021-03-18 | 2022-09-22 | Novocure Gmbh | Constructing a 3d phantom with liquid hydrogel |
| JP2024513854A (ja) | 2021-03-31 | 2024-03-27 | ノボキュア ゲーエムベーハー | 腫瘍治療電場（ＴＴＦｉｅｌｄｓ）システムの電極を使用したインピーダンス断層撮影法 |
| JP2024523598A (ja) | 2021-06-30 | 2024-06-28 | ノボキュア ゲーエムベーハー | 腫瘍治療電場（ＴＴｆｉｅｌｄｓ）を印加するためのトランスデューサアレイにおける電流を調整するためのキャパシタの使用 |
| CN117813131A (zh) | 2021-07-21 | 2024-04-02 | 诺沃库勒有限责任公司 | 生成肿瘤治疗场的导电衬垫及其生产和使用的方法 |
| US11877838B2 (en) * | 2021-08-14 | 2024-01-23 | Nano Hesgarsazan Salamat Arya | Preventing cytokine storm in COVID-19 patients by suppressing clonal expansion in activated lymphocytes using alternating electric fields |
| EP4376939A1 (en) | 2021-09-14 | 2024-06-05 | Novocure GmbH | Temperature independent method and system for applying ttfields |
| US12527954B2 (en) | 2021-09-30 | 2026-01-20 | Novocure Gmbh | Method and system for applying tumor treating fields interfacing with hair follicles |
| US20230168242A1 (en) | 2021-11-29 | 2023-06-01 | Novocure Gmbh | Methods of Reducing Ciliogenesis with Alternating Electric Fields |
| WO2023105391A1 (en) | 2021-12-07 | 2023-06-15 | Novocure Gmbh | Compact dc system for delivering a square wave ac signal |
| US20230173265A1 (en) | 2021-12-10 | 2023-06-08 | Novocure Gmbh | Garment providing a biasing force on a transducer array |
| CN118317809A (zh) | 2021-12-10 | 2024-07-09 | 诺沃库勒有限责任公司 | 用于应用ttfield的压缩服装组件及其制造和使用方法 |
| US12434051B2 (en) | 2021-12-10 | 2025-10-07 | Novocure Gmbh | Compression garment assembly for applying TTFields and methods of production and use thereof |
| US12502548B2 (en) | 2021-12-29 | 2025-12-23 | Novocure Gmbh | Reducing electrosensation whilst treating a subject using alternating electric fields by using larger cathodes and smaller anodes |
| JP2024545019A (ja) | 2021-12-30 | 2024-12-05 | ノボキュア ゲーエムベーハー | 腫瘍治療フィールド（ｔｔｆｉｅｌｄ）を使用した治療のためのパラメータ値の選択 |
| US12478779B2 (en) | 2022-03-29 | 2025-11-25 | Novocure Gmbh | Electrode array having a semi-liquid conductive gel |
| CA3255022A1 (en) | 2022-03-30 | 2023-10-05 | Novocure Gmbh | USE OF INTERLACED COOLING PERIODS TO INCREASE THE MAXIMUM INTENSITY OF TUMOR TREATMENT FIELDS |
| CN119013076A (zh) | 2022-03-30 | 2024-11-22 | 诺沃库勒有限责任公司 | 通过将换能器阵列配对在一起来使用交流电场治疗受试者的同时减少电敏 |
| WO2023193012A2 (en) | 2022-04-01 | 2023-10-05 | The Board Of Regents Of The University Of Texas System | Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy |
| WO2023242741A1 (en) | 2022-06-13 | 2023-12-21 | Novocure Gmbh | Systems and methods for increasing intestinal absorption of therapeutic agents |
| JP2025520608A (ja) | 2022-06-20 | 2025-07-03 | ノボキュア ゲーエムベーハー | 癌を治療するための組成物、システム、および方法、腫瘍治療場およびｖｅｇｆ阻害剤 |
| JP2025520663A (ja) | 2022-06-21 | 2025-07-03 | ノボキュア ゲーエムベーハー | 交流電場とｃｒｉｓｐｒ－ｃａｓシステムを用いた症状および疾患の治療システムおよび方法 |
| WO2024052877A1 (en) | 2022-09-08 | 2024-03-14 | Novocure Gmbh | Constructing a 3d phantom with a matrix material having conductive particles dispersed therein |
| EP4554661A1 (en) | 2022-09-27 | 2025-05-21 | Novocure GmbH | Ingestible implantable device to measure internal ttfield intensity |
| JP2025532765A (ja) | 2022-09-29 | 2025-10-03 | ノボキュア ゲーエムベーハー | 電池交換中にｔｔ場を維持するためのシステムおよび方法 |
| CA3180284A1 (en) | 2022-09-29 | 2024-03-29 | Novocure Gmbh | Transducer array having a temperature sensor isolation layer between a temperature sensor and external environment |
| CN119968221A (zh) | 2022-09-30 | 2025-05-09 | 诺沃库勒有限责任公司 | 用于减少电感应和/或皮肤刺激的组合物、系统和方法 |
| CN119968209A (zh) | 2022-09-30 | 2025-05-09 | 诺沃库勒有限责任公司 | 使用交变电场和树突状细胞治疗癌症的组合物、系统和方法 |
| JP2025533794A (ja) | 2022-09-30 | 2025-10-09 | ノボキュア ゲーエムベーハー | Ｔｔ場用途システム用のシングルワイヤ温度測定ソリューション、ならびにその製造方法および使用方法 |
| JP2025532048A (ja) | 2022-09-30 | 2025-09-29 | ノボキュア ゲーエムベーハー | 交流電場およびアポトーシスがん細胞ワクチンを用いたがん治療のための組成物、システムおよび方法 |
| CN115845254B (zh) * | 2022-11-23 | 2024-02-02 | 湖南安泰康成生物科技有限公司 | 小细胞肺癌治疗系统以及交变电场发生装置 |
| JP2025539300A (ja) | 2022-11-30 | 2025-12-05 | ノボキュア ゲーエムベーハー | 代替アレイ材料を有するトランスデューサアレイ |
| WO2024127192A1 (en) | 2022-12-13 | 2024-06-20 | Novocure Gmbh | Wireless transducer arrays applying tumor treating fields and systems and methods of use thereof |
| JP2026500634A (ja) | 2022-12-28 | 2026-01-08 | ノボキュア ゲーエムベーハー | 癌を治療するための組成物、システム、および方法、腫瘍治療場及び抗ｖｅｇｆｒ－２抗体 |
| US12268863B2 (en) | 2023-02-06 | 2025-04-08 | Novocure Gmbh | Shiftable transducer array with anisotropic material layer |
| WO2024201344A1 (en) | 2023-03-30 | 2024-10-03 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields and chimeric antigen receptor (car)-immune cells |
| AU2024246741A1 (en) | 2023-03-30 | 2025-10-16 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields and killer cells |
| US20240399141A1 (en) | 2023-03-31 | 2024-12-05 | Novocure Gmbh | Microneedles to overcome contact resistance |
| WO2024257051A1 (en) | 2023-06-15 | 2024-12-19 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and thioredoxin/glutathione inhibitors |
| US20250099545A1 (en) | 2023-09-21 | 2025-03-27 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields with immune checkpoint inhibitors and mhc class i activators |
| WO2025068982A1 (en) | 2023-09-28 | 2025-04-03 | Novocure Gmbh | Transducer array having subarrays |
| WO2025068877A1 (en) | 2023-09-29 | 2025-04-03 | Novocure Gmbh | Low frequency rf ablation system |
| WO2025068918A1 (en) | 2023-09-29 | 2025-04-03 | Novocure Gmbh | Apparatus and method of reapplying transducer arrays to a patient |
| TW202528013A (zh) | 2023-09-29 | 2025-07-16 | 瑞士商諾沃庫勒有限責任公司 | 使用振幅和頻率的交錯變化來改善交變電場治療期間的電感覺 |
| WO2025088586A1 (en) | 2023-10-27 | 2025-05-01 | Brown University | Compositions, systems, and methods for treating cancer using tumor treating fields with inhibitors of mif, mica, and/or micb |
| WO2025186743A1 (en) | 2024-03-05 | 2025-09-12 | Novocure Gmbh | Combinations for treating cancer in standard of care and/or profibrotic chemotherapeutic agent-naive patients using tumor treating fields and chemotherapeutic agents |
| TW202547574A (zh) | 2024-03-15 | 2025-12-16 | 瑞士商諾沃庫勒有限責任公司 | 用於施加交流電場之降低阻抗轉換器陣列及其生產與使用方法 |
| US20250367138A1 (en) | 2024-05-31 | 2025-12-04 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and methylglyoxal |
| WO2026003783A1 (en) | 2024-06-27 | 2026-01-02 | Novocure Gmbh | Compositions, systems, and methods for treating cancer using tumor treating fields (ttfields) and nf-κb inhibitors |
| WO2026033423A1 (en) | 2024-08-05 | 2026-02-12 | Novocure Gmbh | Flexible layer for use in a tumor treating fields transducer |
| US20260034376A1 (en) | 2024-08-05 | 2026-02-05 | Novocure Gmbh | Shiftable transducer array with anisotropic material layer and foam layer |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR446660A (fr) | 1911-09-02 | 1912-12-12 | Gottlieb Schuettel | Dispositif pour métiers continus à anneaux pour monter les curseurs sur les anneaux |
| BE794566A (fr) | 1972-01-28 | 1973-07-26 | Esb Inc | Regenerateur et stimulateur bioelectrochimique et procedes d'application in vivo d'energie electrique a des cellules et des tissus. |
| US3991770A (en) | 1974-01-24 | 1976-11-16 | Leveen Harry H | Method for treating benign and malignant tumors utilizing radio frequency, electromagnetic radiation |
| US4016886A (en) | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
| US4121592A (en) | 1975-08-04 | 1978-10-24 | Critical Systems, Inc. | Apparatus for heating tissue |
| DE2907013A1 (de) | 1978-02-24 | 1979-08-30 | American Med Syst | Verfahren und vorrichtung zum beguenstigen der heilung von verletzten knochenknorpeln und geweben im gesichtsbereich |
| DE2813068A1 (de) | 1978-03-25 | 1979-10-04 | Philips Patentverwaltung | Verfahren und vorrichtung zur ermittlung von inneren koerperstrukturen |
| GB2043453A (en) | 1979-02-22 | 1980-10-08 | Electrochem Tech Corp | Improvements in or relating to an electrode |
| US4472506A (en) | 1981-01-13 | 1984-09-18 | Liburdy Robert P | Method for determining cell membrane dielectric breakdown |
| US4467809A (en) | 1982-09-17 | 1984-08-28 | Biolectron, Inc. | Method for non-invasive electrical stimulation of epiphyseal plate growth |
| US4622952A (en) * | 1983-01-13 | 1986-11-18 | Gordon Robert T | Cancer treatment method |
| CA1244889A (en) * | 1983-01-24 | 1988-11-15 | Kureha Chemical Ind Co Ltd | HYPERTHERMIA DEVICE |
| DE3323415C2 (de) | 1983-06-29 | 1985-04-25 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Verwendung eines Verfahrens und einer Vorrichtung zur Bestimmung von Zellinhaltstoffe sezernierenden Zellen |
| SE455920B (sv) | 1986-01-29 | 1988-08-22 | Hans Wiksell | Anordning for hypertermibehandling av tumorer |
| US4923814A (en) * | 1986-05-09 | 1990-05-08 | Electropore, Inc. | High speed, high power apparatus for vesicle prealignment, poration, loading and fusion in uniform electric fields and method therefor |
| CN86103803B (zh) | 1986-06-05 | 1987-11-18 | 北京信息工程学院 | 静电场治疗装置 |
| US4822470A (en) * | 1987-10-09 | 1989-04-18 | Baylor College Of Medicine | Method of and apparatus for cell poration and cell fusion using radiofrequency electrical pulses |
| US4936303A (en) | 1987-11-20 | 1990-06-26 | Ultrathermics | Ultrasonic heating apparatus and method |
| JPH0629196B2 (ja) | 1987-12-01 | 1994-04-20 | 甲子郎 梅村 | 超音波による腫瘍治療用生理作用増強剤 |
| US5389069A (en) | 1988-01-21 | 1995-02-14 | Massachusetts Institute Of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
| FR2627987B3 (fr) | 1988-03-04 | 1990-02-02 | Indiba Sa | Appareil electronique pour la therapie medicale et cosmetique |
| US5158071A (en) * | 1988-07-01 | 1992-10-27 | Hitachi, Ltd. | Ultrasonic apparatus for therapeutical use |
| GB8904998D0 (en) | 1989-03-04 | 1989-04-19 | Matthews Tony | Anaesthetising apparatus |
| US5099756A (en) * | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
| US5441746A (en) * | 1989-12-22 | 1995-08-15 | Molecular Bioquest, Inc. | Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production |
| US5236410A (en) * | 1990-08-02 | 1993-08-17 | Ferrotherm International, Inc. | Tumor treatment method |
| JPH06501410A (ja) * | 1990-11-05 | 1994-02-17 | ビーエスディ・メディカル・コーポレイション | 前立腺過形成治療用電磁容量結合アプリケータ装置 |
| WO1992019286A1 (en) * | 1991-05-03 | 1992-11-12 | University Technologies International, Inc. | Biofilm reduction method |
| US5441532A (en) | 1991-06-26 | 1995-08-15 | Massachusetts Institute Of Technology | Adaptive focusing and nulling hyperthermia annular and monopole phased array applicators |
| US5697909A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
| US5468223A (en) | 1992-11-30 | 1995-11-21 | C.N.R.S. Paris | Electrochemotherapy |
| US5386837A (en) * | 1993-02-01 | 1995-02-07 | Mmtc, Inc. | Method for enhancing delivery of chemotherapy employing high-frequency force fields |
| FR2703253B1 (fr) * | 1993-03-30 | 1995-06-23 | Centre Nat Rech Scient | Applicateur d'impulsions electriques pour traitement de tissus biologiques. |
| US5458597A (en) * | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
| IL108775A (en) | 1994-02-25 | 2003-09-17 | Univ Ramot | Method for efficient incorporation of molecules into cells |
| US5704355A (en) | 1994-07-01 | 1998-01-06 | Bridges; Jack E. | Non-invasive system for breast cancer detection |
| AU6639596A (en) | 1995-07-28 | 1997-02-26 | James R. Gray | Use of a polarizing field to modify the efficacy of a bioactive agent |
| US5606971A (en) * | 1995-11-13 | 1997-03-04 | Artann Corporation, A Nj Corp. | Method and device for shear wave elasticity imaging |
| US5718246A (en) | 1996-01-03 | 1998-02-17 | Preferential, Inc. | Preferential induction of electrically mediated cell death from applied pulses |
| US5984882A (en) * | 1996-08-19 | 1999-11-16 | Angiosonics Inc. | Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy |
| US5869326A (en) | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
| US6055453A (en) * | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
| AU9472998A (en) * | 1997-09-04 | 1999-03-22 | Science Research Laboratory, Inc. | Cell separation using electric fields |
| US6027488A (en) * | 1998-06-03 | 2000-02-22 | Genetronics, Inc. | Flow-through electroporation system for ex vivo gene therapy |
| US5976092A (en) * | 1998-06-15 | 1999-11-02 | Chinn; Douglas O. | Combination stereotactic surgical guide and ultrasonic probe |
| US6319901B1 (en) | 1998-10-15 | 2001-11-20 | Ichor Medical Systems, Inc. | Methods for prolonging cell membrane permeability |
| CA2364098C (en) | 1999-03-09 | 2010-11-16 | Thermage, Inc. | Apparatus and method for treatment of tissue |
| US6678558B1 (en) * | 1999-03-25 | 2004-01-13 | Genetronics, Inc. | Method and apparatus for reducing electroporation-mediated muscle reaction and pain response |
| US6366808B1 (en) | 2000-03-13 | 2002-04-02 | Edward A. Schroeppel | Implantable device and method for the electrical treatment of cancer |
| US6853864B2 (en) * | 2000-02-02 | 2005-02-08 | Catholic University Of America, The | Use of electromagnetic fields in cancer and other therapies |
| US6868289B2 (en) | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
| US7089054B2 (en) | 2002-10-02 | 2006-08-08 | Standen Ltd. | Apparatus and method for treating a tumor or the like |
| JP5280600B2 (ja) | 2000-02-17 | 2013-09-04 | パルティ、ヨーラム | 分裂中の細胞を破壊するための方法および装置 |
| US8175698B2 (en) | 2000-02-17 | 2012-05-08 | Novocure Ltd. | Treating bacteria with electric fields |
| US7146210B2 (en) | 2000-02-17 | 2006-12-05 | Standen Ltd. | Apparatus and method for optimizing tumor treatment efficiency by electric fields |
| US7136699B2 (en) | 2002-10-02 | 2006-11-14 | Standen, Ltd. | Apparatus for destroying dividing cells |
| US7016725B2 (en) | 2001-11-06 | 2006-03-21 | Standen Ltd. | Method and apparatus for destroying dividing cells |
| US7599746B2 (en) | 2000-02-17 | 2009-10-06 | Standen Ltd | Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases |
| US6546290B1 (en) | 2000-04-12 | 2003-04-08 | Roamitron Holding S.A. | Method and apparatus for electromedical therapy |
| US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
| JP4750784B2 (ja) | 2004-04-23 | 2011-08-17 | ノヴォキュアー・リミテッド | 異なる周波数の電界による腫瘍等の治療 |
| DE102004028156A1 (de) | 2004-06-09 | 2006-01-05 | Kalbe, Jochen, Dr. | Kombination von Radiowellen mit pharmakologisch aktiven Substanzen |
| WO2006061688A1 (en) | 2004-12-07 | 2006-06-15 | Standen Ltd. | Electrodes for applying an electric field in-vivo over an extended period of time |
| JP5559460B2 (ja) | 2004-12-27 | 2014-07-23 | スタンデン・リミテッド | 異なる配向の電界を用いて腫瘍またはその類似物を処理する方法 |
| US20060282122A1 (en) | 2005-06-08 | 2006-12-14 | Yoram Palti | Treating cancer with electric fields that are guided to desired locations within a body |
| DK1933937T3 (en) | 2005-10-03 | 2015-04-07 | Novocure Ltd | OPTIMIZATION OF THE CHARACTERISTICS OF AN ELECTRIC FIELD FOR ENHANCING FIELD EFFECT ON proliferating cells |
| US8019414B2 (en) | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
| US8465533B2 (en) | 2007-03-06 | 2013-06-18 | Novocure Limited | Treating cancer using electromagnetic fields in combination with photodynamic therapy |
| EP2183024B1 (en) | 2007-08-14 | 2019-05-15 | Novocure Ltd. | Treating parasites with electric fields |
| US8715203B2 (en) | 2007-09-17 | 2014-05-06 | Novocure Limited | Composite electrode |
-
2001
- 2001-02-16 JP JP2001560365A patent/JP5280600B2/ja not_active Expired - Lifetime
- 2001-02-16 CA CA2400526A patent/CA2400526C/en not_active Expired - Lifetime
- 2001-02-16 WO PCT/IB2001/000202 patent/WO2001060994A1/en not_active Ceased
- 2001-02-16 EP EP10012031A patent/EP2335776A1/en not_active Ceased
- 2001-02-16 AU AU33998/01A patent/AU3399801A/en not_active Abandoned
- 2001-02-16 EP EP01906036A patent/EP1259596A4/en not_active Ceased
- 2001-02-16 US US10/204,334 patent/US7333852B2/en not_active Ceased
- 2001-02-16 CN CN01806416A patent/CN1416466A/zh active Pending
- 2001-02-16 US US12/199,498 patent/USRE43618E1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3399801A (en) | 2001-08-27 |
| JP2004505604A (ja) | 2004-02-26 |
| USRE43618E1 (en) | 2012-08-28 |
| EP2335776A1 (en) | 2011-06-22 |
| WO2001060994A1 (en) | 2001-08-23 |
| US20030150372A1 (en) | 2003-08-14 |
| CN1416466A (zh) | 2003-05-07 |
| JP5280600B2 (ja) | 2013-09-04 |
| CA2400526A1 (en) | 2001-08-23 |
| EP1259596A4 (en) | 2004-12-22 |
| EP1259596A1 (en) | 2002-11-27 |
| US7333852B2 (en) | 2008-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2400526C (en) | Method and apparatus for destroying dividing cells | |
| US7016725B2 (en) | Method and apparatus for destroying dividing cells | |
| JP2004505604A5 (enExample) | ||
| US7519420B2 (en) | Apparatus for selectively destroying dividing cells | |
| CA2563817C (en) | Treating a tumor or the like with electric fields at different frequencies | |
| EP2183024B1 (en) | Treating parasites with electric fields | |
| US7146210B2 (en) | Apparatus and method for optimizing tumor treatment efficiency by electric fields | |
| US8175698B2 (en) | Treating bacteria with electric fields | |
| WO2006085150A2 (en) | Treating a tumor or the like with electric fields at different orientations | |
| HK1139089B (en) | Treating parasites with electric fields | |
| HK1139089A (en) | Treating parasites with electric fields |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20210216 |